Shoko Ukita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shoko Ukita has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Genta Toshima
Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan
3 shared publications - Keisuke Kataoka
Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
2 shared publications - Kengo Nagashima
Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan
2 shared publications Masatoshi Sakurai
Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
2 shared publicationsAmi Inokuchi
Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
1 shared publicationEri Matsuki
Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 2 December 2025
- Published by Springer Nature in Blood Cancer Journal
- Vol. 16 (1)
Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study
Autoimmune diseases (AIDs) are associated with an increased risk of lymphoma. Although treatment strategies have changed substantially in AIDs, recent evidence regarding this association is lacking. Particularly, the impact of novel immunosuppressive/immunomodulatory agents and the cumulative effect of multiple medication use on lymphoma risk have not been well investigated. To address these, we used the LIFE Study database, which contains health care claims data from 2014 to 2023 in 15 municipalities in Japan. Of 2,229,423 individuals, 211,592 had AIDs and 530 subsequently developed lymphoma. Overall, AID cases had a significantly higher incidence of lymphoma than non-AID cases (hazard ratio [HR] 1.9). Among 23 AIDs, lymphoma risk was significantly elevated in 14, including Takayasu arteritis (6.6) and adult-onset Still’s disease (4.7). Among immunosuppressive/immunomodulatory agents, calcineurin inhibitors, iguratimod, or methotrexate were associated with higher lymphoma risks. Importantly, the use of two or more medications strongly increased lymphoma risk (HR 2.7) in AID cases. Lymphoma subtype-specific analysis revealed novel associations, including T/NK-cell lymphoma in systemic lupus erythematosus. Our large-scale cohort study reveals an increased risk of lymphoma in AID patients, particularly those receiving multiple immunosuppressants/immunomodulators, underscoring the need for careful monitoring in these patients.
- 2 December 2025
- Published by Springer Nature in Blood Cancer Journal
- Vol. 16 (1)
Open AccessLymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study
Autoimmune diseases (AIDs) are associated with an increased risk of lymphoma. Although treatment strategies have changed substantially in AIDs, recent evidence regarding this association is lacking. Particularly, the impact of novel immunosuppressive/immunomodulatory agents and the cumulative effect of multiple medication use on lymphoma risk have not been well investigated. To address these, we used the LIFE Study database, which contains health care claims data from 2014 to 2023 in 15 municipalities in Japan. Of 2,229,423 individuals, 211,592 had AIDs and 530 subsequently developed lymphoma. Overall, AID cases had a significantly higher incidence of lymphoma than non-AID cases (hazard ratio [HR] 1.9). Among 23 AIDs, lymphoma risk was significantly elevated in 14, including Takayasu arteritis (6.6) and adult-onset Still’s disease (4.7). Among immunosuppressive/immunomodulatory agents, calcineurin inhibitors, iguratimod, or methotrexate were associated with higher lymphoma risks. Importantly, the use of two or more medications strongly increased lymphoma risk (HR 2.7) in AID cases. Lymphoma subtype-specific analysis revealed novel associations, including T/NK-cell lymphoma in systemic lupus erythematosus. Our large-scale cohort study reveals an increased risk of lymphoma in AID patients, particularly those receiving multiple immunosuppressants/immunomodulators, underscoring the need for careful monitoring in these patients.
- Open Access
- 19 May 2025
- Published by Wiley in American Journal of Hematology
- Vol. 100 (8) , 1283-1294
Classical and Late‐Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis
Sinusoidal obstruction syndrome/veno‐occlusive disease (SOS/VOD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). According to the 2016 European Society for Blood and Marrow Transplantation criteria, SOS/VOD is classified into classical SOS/VOD and late‐onset SOS/VOD, but their similarities and differences remain unclear. Here we retrospectively investigated the incidence, risk factors, and impact on transplant outcomes of classical and late‐onset SOS/VOD in 16 518 allo‐HSCT recipients using the Japanese nationwide registry data. The cumulative incidences of classical and late‐onset SOS/VOD were 2.5% and 2.2%, with a median onset of 13 and 42 days after transplantation, respectively. Both patients with classical (hazard ratio [HR], 3.45; 95% CI, 3.07–3.87) and late‐onset (HR, 3.98; 95% CI, 3.51–4.51) SOS/VOD had a significantly worse overall survival compared with those without. The risk factors for classical and late‐onset SOS/VOD are different. Hepatic comorbidities, high‐risk diseases, use of melphalan (MEL), and myeloablative conditioning are associated with both types of SOS/VOD. Whereas poor performance status, a prior history of transplantation, and positive hepatitis C virus are associated with only classical SOS/VOD, allo‐HSCT from cord blood or related human leukocyte antigen‐haploidentical donors, use of total body irradiation and busulfan (BU), and tacrolimus‐based graft‐versus‐host disease prophylaxis are associated with only late‐onset SOS/VOD. In particular, the incidence of late‐onset SOS/VOD is much higher in patients receiving both BU‐ and MEL‐containing conditioning regimens. These findings suggest that different monitoring and treatment approaches are necessary for allo‐HSCT recipients at high risk for classical and late‐onset SOS/VOD.
- 19 May 2025
- Published by Wiley in American Journal of Hematology
- Vol. 100 (8) , 1283-1294
Open AccessClassical and Late‐Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis
Sinusoidal obstruction syndrome/veno‐occlusive disease (SOS/VOD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). According to the 2016 European Society for Blood and Marrow Transplantation criteria, SOS/VOD is classified into classical SOS/VOD and late‐onset SOS/VOD, but their similarities and differences remain unclear. Here we retrospectively investigated the incidence, risk factors, and impact on transplant outcomes of classical and late‐onset SOS/VOD in 16 518 allo‐HSCT recipients using the Japanese nationwide registry data. The cumulative incidences of classical and late‐onset SOS/VOD were 2.5% and 2.2%, with a median onset of 13 and 42 days after transplantation, respectively. Both patients with classical (hazard ratio [HR], 3.45; 95% CI, 3.07–3.87) and late‐onset (HR, 3.98; 95% CI, 3.51–4.51) SOS/VOD had a significantly worse overall survival compared with those without. The risk factors for classical and late‐onset SOS/VOD are different. Hepatic comorbidities, high‐risk diseases, use of melphalan (MEL), and myeloablative conditioning are associated with both types of SOS/VOD. Whereas poor performance status, a prior history of transplantation, and positive hepatitis C virus are associated with only classical SOS/VOD, allo‐HSCT from cord blood or related human leukocyte antigen‐haploidentical donors, use of total body irradiation and busulfan (BU), and tacrolimus‐based graft‐versus‐host disease prophylaxis are associated with only late‐onset SOS/VOD. In particular, the incidence of late‐onset SOS/VOD is much higher in patients receiving both BU‐ and MEL‐containing conditioning regimens. These findings suggest that different monitoring and treatment approaches are necessary for allo‐HSCT recipients at high risk for classical and late‐onset SOS/VOD.
- Open Access
- 7 January 2025
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 67 (1)
Increased risk of proximal tubular dysfunction due to occupational cadmium exposure: a survival analysis study
Objectives: The objective of the current study was to elucidate the relationship between blood cadmium (Cd-B) levels and proximal tubular dysfunction using urinary β2-microglobulin (B2M-U) as an indicator among workers in nickel-cadmium battery plants in Japan. Methods: Medical check-up data from 338 workers exposed to cadmium at 2 plants were collected from 1997 through 2020. Workers with at least 2 check-ups were included, excluding those with other renal dysfunctions. Proximal tubular dysfunction was defined as a B2M-U of 300 μg/g creatinine or higher in 2 or more consecutive check-ups. A multivariable Cox proportional-hazards regression model with time-dependent covariates was performed to analyze the relationship between Cd-B levels and the time to onset of proximal tubular dysfunction, adjusting for age, sex, and smoking history. Results: Of the 338 workers, 238 met the study eligibility criteria for the analyses. The geometric mean of Cd-B was 1.97 μg/L. The Cox proportional hazards analysis demonstrated that higher time-dependent Cd-B levels were significantly associated with an increased risk of proximal tubular dysfunction, with a hazard ratio of 1.17 (95% CI: 1.06-1.29). Conclusions: Higher Cd-B levels are associated with an increased risk of proximal tubular dysfunction in workers exposed to cadmium, indicating an increased risk of renal disease under the current industrial health management in Japan. Continuous monitoring and improved management of cadmium exposure are necessary to protect workers’ health even in developed countries such as Japan.
- 7 January 2025
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 67 (1)
Open AccessIncreased risk of proximal tubular dysfunction due to occupational cadmium exposure: a survival analysis study
Objectives: The objective of the current study was to elucidate the relationship between blood cadmium (Cd-B) levels and proximal tubular dysfunction using urinary β2-microglobulin (B2M-U) as an indicator among workers in nickel-cadmium battery plants in Japan. Methods: Medical check-up data from 338 workers exposed to cadmium at 2 plants were collected from 1997 through 2020. Workers with at least 2 check-ups were included, excluding those with other renal dysfunctions. Proximal tubular dysfunction was defined as a B2M-U of 300 μg/g creatinine or higher in 2 or more consecutive check-ups. A multivariable Cox proportional-hazards regression model with time-dependent covariates was performed to analyze the relationship between Cd-B levels and the time to onset of proximal tubular dysfunction, adjusting for age, sex, and smoking history. Results: Of the 338 workers, 238 met the study eligibility criteria for the analyses. The geometric mean of Cd-B was 1.97 μg/L. The Cox proportional hazards analysis demonstrated that higher time-dependent Cd-B levels were significantly associated with an increased risk of proximal tubular dysfunction, with a hazard ratio of 1.17 (95% CI: 1.06-1.29). Conclusions: Higher Cd-B levels are associated with an increased risk of proximal tubular dysfunction in workers exposed to cadmium, indicating an increased risk of renal disease under the current industrial health management in Japan. Continuous monitoring and improved management of cadmium exposure are necessary to protect workers’ health even in developed countries such as Japan.
- 12 June 2024
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 18 (6) , e1035-e1045
Obstructive sleep apnea syndrome attenuated high-density lipoprotein function
- 12 June 2024
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 18 (6) , e1035-e1045
Obstructive sleep apnea syndrome attenuated high-density lipoprotein function
- Open Access
- 18 February 2024
- Published by MDPI AG in Geriatrics
- Vol. 9 (1) , 21
Synergistic Effect of Motivation for the Elderly and Support for Going Out II: Measures to Induce Elderly Men to Go Out
Background: The second demonstration experiment of supporting elderly people going out with the Choisoko system was conducted. The first study showed that for women, friends, shopping, convenience, and events are factors that have the potential to be effective motivational factors for encouraging these women to go out. On the other hand, these factors did not lead to any behavioral change in men. Since there are approximately 15 million men over the age of 65 in Japan, behavioral changes in the entire elderly population will not occur without guidance for elderly men to go out. Methods: Sixteen elderly men and forty-seven elderly women participated. Interestingly, men are far more passionate about games than women. Therefore, we hypothesized that a preference for games could be a hint as to how we might encourage older men to go out. Then, a second demonstration experiment was conducted, and we analyzed the relationship between six game preferences and the frequency of going out. Results: Among gaming preferences, men with gaming preferences such as Philanthropists, Achievers, and Free Spirits showed a tendency to go out. Conclusions: These stimuli may have the potential to be factors that may encourage elderly men to go out.
- 18 February 2024
- Published by MDPI AG in Geriatrics
- Vol. 9 (1) , 21
Open AccessSynergistic Effect of Motivation for the Elderly and Support for Going Out II: Measures to Induce Elderly Men to Go Out
Background: The second demonstration experiment of supporting elderly people going out with the Choisoko system was conducted. The first study showed that for women, friends, shopping, convenience, and events are factors that have the potential to be effective motivational factors for encouraging these women to go out. On the other hand, these factors did not lead to any behavioral change in men. Since there are approximately 15 million men over the age of 65 in Japan, behavioral changes in the entire elderly population will not occur without guidance for elderly men to go out. Methods: Sixteen elderly men and forty-seven elderly women participated. Interestingly, men are far more passionate about games than women. Therefore, we hypothesized that a preference for games could be a hint as to how we might encourage older men to go out. Then, a second demonstration experiment was conducted, and we analyzed the relationship between six game preferences and the frequency of going out. Results: Among gaming preferences, men with gaming preferences such as Philanthropists, Achievers, and Free Spirits showed a tendency to go out. Conclusions: These stimuli may have the potential to be factors that may encourage elderly men to go out.